Clinical Trials Browser

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

NCT07450287 2026-03-04

CardioNETPOL

Not yet recruiting

120 enrolled

EndocrineNET

Carcinoid Heart Disease, Heart Failure, Heart Valve Diseases, Neuroendocrine Tumors, Serotonin Syndrome

NCT04993261 2026-02-19

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

Phase EARLY_PHASE1 Active not recruiting

71 enrolled

Endocrine

Carcinoid Tumor, Serotonin Syndrome

NCT05361668 2025-10-31

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

Phase 2 Active not recruiting

36 enrolled 19 charts

EndocrineNET

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

NCT05064514 2025-05-01

TRICAR

Phase NA Active not recruiting

15 enrolled

Endocrine

Carcinoid Heart Disease, Carcinoid Tumor, Tricuspid Valve Insufficiency, Serotonin Syndrome

NCT03223428 2024-07-24

RELAX

Completed

223 enrolled 16 charts

EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

NCT04713202 2023-02-10

NET-PACS

Phase 2 Withdrawn

EndocrineNET

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

NCT03722511 2022-11-03

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

Phase 2 Completed

10 enrolled

EndocrineNET

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

NCT00774930 2022-10-14

ELECT

Phase 3 Completed

115 enrolled 17 charts

EndocrineNET

Carcinoid Tumor, Diarrhea, Flushing, Neuroendocrine Tumors, Serotonin Syndrome

NCT04073017 2021-05-21

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

Phase NA Terminated

11 enrolled

EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

NCT01234168 2020-11-05

SYMNET

Completed

340 enrolled

EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

NCT04039516 2020-08-04

CHARRT

Phase 2 Unknown

20 enrolled

Endocrine

Carcinoid Heart Disease, Carcinoid Tumor, Serotonin Syndrome

NCT00092287 2020-04-30

Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

Phase 3 Terminated

4 enrolled

Endocrine

Malignant Carcinoid Syndrome, Serotonin Syndrome

NCT04065165 2020-02-05

TELEFIRST

Phase 3 Withdrawn

Endocrine

Carcinoid Heart Disease, Serotonin Syndrome

NCT04140409 2019-10-25

SCIROCCO

Phase 4 Terminated

10 enrolled

EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

NCT02299089 2017-12-15

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Phase 2 Completed

12 enrolled 18 charts

EndocrineNET

Acromegaly, Neuroendocrine Tumors, Serotonin Syndrome

NCT01172717 2013-07-26

Study of Panitumumab in the Treatment of Carcinoid Syndrome

Phase 2 Withdrawn

Endocrine

Carcinoid Tumor, Serotonin Syndrome

NCT00088595 2012-06-04

Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors

Phase 2 Completed

45 enrolled 10 charts

Endocrine

Carcinoid Tumor, Serotonin Syndrome

NCT00789841 2010-10-26

Gastrointestinal Motility in Patients With Neuroendocrine Tumors

Completed

13 enrolled

EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

Clinical Trials

CAREFNDR

CardioNETPOL

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

TRICAR

RELAX

NET-PACS

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

ELECT

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

SYMNET

CHARRT

Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

TELEFIRST

SCIROCCO

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Study of Panitumumab in the Treatment of Carcinoid Syndrome

Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors

Gastrointestinal Motility in Patients With Neuroendocrine Tumors